SHARE
COPY LINK

COVID-19

IN NUMBERS: What’s the latest on Switzerland’s vaccination programme?

How many people have had the vaccine in Switzerland now and what about the number of people who have suffered adverse side affects? And what's the waiting time to get vaccinated? This article will bring you up to date.

IN NUMBERS: What's the latest on Switzerland's vaccination programme?
Inoculation process is ongoing in Switzerland. Photo by AFP

Three percent

However, this number should go up to 8 percent by the end of February, and gradually increase after that, said Nora Kronig, vice-director of the Federal Office of Public Health (FOPH).

About 290,000 doses still remain in Switzerland and more are expected to be delivered soon, Kronig said. 

The number of vaccines distributed to each canton is based on the number of residents, so it is not surprising that Zurich, the most populous canton, got the highest number of doses — 65,675.
Next are Vaud (40,00) and Bern (39,250).

In all, the government purchased 13 million doses of Covid vaccine from three manufacturers — Pfizer (3 million doses), Moderna (4.5 million) and AstraZeneca (5.3 million).

So far, only the Pfizer and Moderna vaccines have been approved for use in Switzerland.

READ MORE: EXPLAINED: Five questions about Covid-19 vaccines in Switzerland 

42 adverse reactions

Out of approximately 170,000 vaccines administered in the Swiss cantons to date, only 42 reports of side effects were recorded, according to the country’s drug authorisation agency, Swissmedic. 

Of the 42 cases, 26 were not serious, involving mild reactions, Swissmedic reported.

The others were classified as serious and five had “a fatal outcome”.

The agency added that the five patients who passed away “were aged between 84 and 92 and, according to the latest available information, died of illnesses that commonly occur at this age. Despite a chronological correlation with the vaccination, there is no concrete evidence to suggest that the vaccination was the cause of death”.

“So far this analysis has not resulted in any change in the positive benefit/risk ratio of the vaccines”.

The Federal Office of Public Health (FOPH) defined “serious damage” as the one “leading to significant health or economic effects for the vaccinated person. Temporary or lasting incapacity for work, for example, constitutes serious damage”.

On the other hand, minor side effects like redness or swelling caused by injection, headache, muscle pain, or slight fever, all of which are normal temporary reactions to any vaccine, are not considered to be severe.

End of June?

There are several reasons why this is the case.

First, because some cantons have used up their supply of vaccines and are waiting for the delivery of more doses.

Two doses are reserved for each person. Once a patient gets the first dose, they immediately get an appointment for the second one about a month later, and that dose is saved for them.

READ MORE: Covid-19: Why Switzerland has to portion out its vaccine vials

The second reason why the process is slow is because the vaccination is done by priority groups.

Right now, only people over 75 or those suffering from serious chronic conditions are getting the shots.

Risk factors — and therefore eligibility for the shot — are determined through an online questionnaire. Some cantons require a doctor’s note to confirm that a patient is in the high-risk group qualifying for the early vaccine. Other cantons rely on an honor system.

But health officials said that everyone who wants to be vaccinated will get the shots by the end of June.

 

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Public Health Agency recommends two Covid doses next year for elderly

Sweden's Public Health Agency is recommending that those above the age of 80 should receive two doses of a Covid-19 vaccine a year, once in the spring and once in the autumn, as it shifts towards a longer-term strategy for the virus.

Public Health Agency recommends two Covid doses next year for elderly

In a new recommendation, the agency said that those living in elderly care centres, and those above the age of 80 should from March 1st receive two vaccinations a year, with a six month gap between doses. 

“Elderly people develop a somewhat worse immune defence after vaccination and immunity wanes faster than among young and healthy people,” the agency said. “That means that elderly people have a greater need of booster doses than younger ones. The Swedish Public Health Agency considers, based on the current knowledge, that it will be important even going into the future to have booster doses for the elderly and people in risk groups.” 

READ ALSO: 

People between the ages of 65 and 79 years old and young people with risk factors, such as obesity, diabetes, poor kidney function or high blood pressure, are recommended to take one additional dose per year.

The new vaccination recommendation, which will start to apply from March 1st next year, is only for 2023, Johanna Rubin, the investigator in the agency’s vaccination programme unit, explained. 

She said too much was still unclear about how long protection from vaccination lasted to institute a permanent programme.

“This recommendation applies to 2023. There is not really an abundance of data on how long protection lasts after a booster dose, of course, but this is what we can say for now,” she told the TT newswire. 

It was likely, however, that elderly people would end up being given an annual dose to protect them from any new variants, as has long been the case with influenza.

SHOW COMMENTS